Bhaskar Anand - 29 Apr 2025 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Chief Accounting Officer
Signature
/s/ Bhaskar Anand
Issuer symbol
SMMT
Transactions as of
29 Apr 2025
Net transactions value
$0
Form type
4
Filing time
01 May 2025, 18:17:22 UTC
Previous filing
14 Jan 2025
Next filing
19 Sep 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMMT Stock Option (right to buy) Award +600,000 600,000 29 Apr 2025 Common Stock 600,000 $3.85 Direct F1, F2
transaction SMMT Stock Option (right to buy) Award +75,000 75,000 29 Apr 2025 Common Stock 75,000 $17.85 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effective April 29, 2025, these stock options were amended from performance-based stock options to time-based stock options. The shares underlying the option vest in four equal annual installments, with the first such installment occurring on December 31, 2025.
F2 Not applicable.
F3 Effective April 29, 2025, these stock options were amended from performance-based stock options to time-based stock options. The shares underlying the option vest in four equal annual installments, with the first such installment occurring on January 12, 2026.